Shared Care

Below you can find prescribing guidelines and their review dates

Principles of shared care protocols and guidelines

Amiodarone - Review date extended to January 2023

Attention deficit/hyperactivity disorder (ADHD) - June 2022

Sheffield Place: Shortage of methylphenidate prolonged-release capsules and tablets, lisdexamfetamine capsules, and guanfacine prolonged-release tablets - update October 2023

ADULTS: Information for patients, families, and carers - Shortage of medicines for ADHD (Attention Deficit Hyperactivity Disorder) in Adults

CHILDREN: Information for parents and carers with children under the care of Ryegate Neurodisability/CAMHD ADHD teams

Azathioprine and Mercaptopurine in adults and young people over 16 years - July 2022

Bipolar disorder -  February 2023

Cinacalcet - February 2026

Dalteparin - June 2021

Dementia - Prescribing of Cognitive Enhancers  -  Review date extended to April 2024

Denosumab (Prolia ®▼)  -  October 2022

DMARDs monitoring quick reference guide - Review date extended to  February 2024

   Please refer to individual shared care guidelines for more detailed information

   New DMARD Toolkit Searches to help monitor patients and provide accurate data for audit 

Efmody® - The Use of Efmody® in Patients with Adrenal Insufficiency (CAH) - SY ICB

Epilepsy in adults -  SY ICB

Epilepsy in children  -  September 2021

Growth hormone: The treatment of Adults with Growth Hormone (Somatropin) -  Review date extended to March 2023

Growth hormone - Treatment of children with recombinant human growth hormone - November 2028

Hydroxychloroquine - January 2023

Leflunomide  - October 2025

Melatonin in the treatment of sleep disorders in children  - September 2025

Methotrexate - February 2029

National Shared Care Transfer Forms 

Safe handling of subcutaneous methotrexate

Midodrine - March 2027

Modafinil – February 2025

Mycophenolate - February 2026

Nebulised Colomycin®, gentamicin or tobramycin in adults with non-cystic fibrosis bronchiectasis - September 2026

Parkinson’s disease - SY ICB

Prostatic Cancer - Hormonal Management of Prostatic Cancer  January 2021

Rifaxamin for Hepatic Encephalopathy - January 2024

Riluzole - August 2025

Sublingual Immunotherapy (SLIT) (Grazax®/Acarizax®) - For adults and children diagnosed with severe allergic rhinitis to grass pollen or house dust mite - SY ICB

Sulfasalazine - Review date extended to November 2022

SSRIs in children and young people - June 2025

Topical testosterone replacement therapy in menopausal women- December 2027

Triptorelin for the treatment of Central Precocious Puberty in Children - February 2025

Last updated on 27/02/2024 by deborahmorris8